TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2016 DA - 2016// TI - Cancer statistics, 2016 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21332 DO - 10.3322/caac.21332 ID - Siegel2016 ER - TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. AU - Zhang, S. AU - Zeng, H. AU - Bray, F. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - Arruebo, M. AU - Vilaboa, N. AU - Saez-Gutierrez, B. AU - Lambea, J. AU - Tres, A. AU - Valladares, M. PY - 2011 DA - 2011// TI - Assessment of the evolution of cancer treatment therapies JO - Cancers VL - 3 UR - https://doi.org/10.3390/cancers3033279 DO - 10.3390/cancers3033279 ID - Arruebo2011 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Chae, Y. K. AU - Pan, A. P. AU - Davis, A. A. AU - Patel, S. P. AU - Carneiro, B. A. AU - Kurzrock, R. PY - 2017 DA - 2017// TI - Path toward precision oncology: review of targeted therapy studies and tools to aid in defining “Actionability” of a molecular lesion and patient management support JO - Mol Cancer Ther VL - 16 UR - https://doi.org/10.1158/1535-7163.MCT-17-0597 DO - 10.1158/1535-7163.MCT-17-0597 ID - Chae2017 ER - TY - JOUR AU - Dustin, M. L. PY - 2016 DA - 2016// TI - Cancer immunotherapy: killers on sterols JO - Nature VL - 531 UR - https://doi.org/10.1038/nature17310 DO - 10.1038/nature17310 ID - Dustin2016 ER - TY - JOUR AU - Judson, P. L. AU - Abdallah, R. AU - Xiong, Y. AU - Ebbert, J. AU - Lancaster, J. M. PY - 2017 DA - 2017// TI - Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center JO - Integr Cancer Ther. VL - 16 UR - https://doi.org/10.1177/1534735416660384 DO - 10.1177/1534735416660384 ID - Judson2017 ER - TY - JOUR AU - Carmady, B. AU - Smith, C. A. PY - 2011 DA - 2011// TI - Use of Chinese medicine by cancer patients: a review of surveys JO - Chin Med. VL - 6 UR - https://doi.org/10.1186/1749-8546-6-22 DO - 10.1186/1749-8546-6-22 ID - Carmady2011 ER - TY - JOUR AU - Liu, J. AU - Wang, S. AU - Zhang, Y. AU - Fan, H. T. AU - Lin, H. S. PY - 2015 DA - 2015// TI - Traditional Chinese medicine and cancer: history, present situation, and development JO - Thorac Cancer. VL - 6 UR - https://doi.org/10.1111/1759-7714.12270 DO - 10.1111/1759-7714.12270 ID - Liu2015 ER - TY - JOUR AU - Hsiao, W. L. AU - Liu, L. PY - 2010 DA - 2010// TI - The role of traditional Chinese herbal medicines in cancer therapy—from TCM theory to mechanistic insights JO - Planta Med VL - 76 UR - https://doi.org/10.1055/s-0030-1250186 DO - 10.1055/s-0030-1250186 ID - Hsiao2010 ER - TY - JOUR AU - Zhang, Y. AU - Liang, Y. AU - He, C. PY - 2017 DA - 2017// TI - Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine JO - Chin Med. VL - 12 UR - https://doi.org/10.1186/s13020-017-0140-2 DO - 10.1186/s13020-017-0140-2 ID - Zhang2017 ER - TY - JOUR AU - Gill, H. AU - Yim, R. AU - Lee, H. K. K. AU - Mak, V. AU - Lin, S. Y. AU - Kho, B. PY - 2018 DA - 2018// TI - Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: a 15-year prospective study JO - Cancer VL - 124 UR - https://doi.org/10.1002/cncr.31327 DO - 10.1002/cncr.31327 ID - Gill2018 ER - TY - JOUR AU - Rockwell, S. AU - Grove, T. A. AU - Liu, Y. AU - Cheng, Y. C. AU - Higgins, S. A. AU - Booth, C. J. PY - 2013 DA - 2013// TI - Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy JO - Int J Radiat Biol VL - 89 UR - https://doi.org/10.3109/09553002.2012.717733 DO - 10.3109/09553002.2012.717733 ID - Rockwell2013 ER - TY - JOUR AU - Katz, L. AU - Baltz, R. H. PY - 2016 DA - 2016// TI - Natural product discovery: past, present, and future JO - J Ind Microbiol Biotechnol VL - 43 UR - https://doi.org/10.1007/s10295-015-1723-5 DO - 10.1007/s10295-015-1723-5 ID - Katz2016 ER - TY - JOUR AU - Tan, W. AU - Lu, J. AU - Huang, M. AU - Li, Y. AU - Chen, M. AU - Wu, G. PY - 2011 DA - 2011// TI - Anti-cancer natural products isolated from chinese medicinal herbs JO - Chin Med. VL - 6 UR - https://doi.org/10.1186/1749-8546-6-27 DO - 10.1186/1749-8546-6-27 ID - Tan2011 ER - TY - JOUR AU - Swinney, D. PY - 2013 DA - 2013// TI - Phenotypic vs. target-based drug discovery for first-in-class medicines JO - Clin Pharmacol Ther VL - 93 UR - https://doi.org/10.1038/clpt.2012.236 DO - 10.1038/clpt.2012.236 ID - Swinney2013 ER - TY - JOUR AU - Siddik, Z. H. PY - 2003 DA - 2003// TI - Cisplatin: mode of cytotoxic action and molecular basis of resistance JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206933 DO - 10.1038/sj.onc.1206933 ID - Siddik2003 ER - TY - JOUR AU - Crown, J. AU - O’leary, M. PY - 2000 DA - 2000// TI - The taxanes: an update JO - Lancet. VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02074-2 DO - 10.1016/S0140-6736(00)02074-2 ID - Crown2000 ER - TY - JOUR AU - Johnson, R. K. PY - 1990 DA - 1990// TI - Screening methods in antineoplastic drug discovery JO - J Natl Cancer Inst VL - 82 UR - https://doi.org/10.1093/jnci/82.13.1082 DO - 10.1093/jnci/82.13.1082 ID - Johnson1990 ER - TY - JOUR AU - Rowinsky, E. K. AU - Calvo, E. PY - 2006 DA - 2006// TI - Novel agents that target tublin and related elements JO - Semin Oncol VL - 33 UR - https://doi.org/10.1053/j.seminoncol.2006.04.006 DO - 10.1053/j.seminoncol.2006.04.006 ID - Rowinsky2006 ER - TY - JOUR AU - Newlands, E. AU - Stevens, M. AU - Wedge, S. AU - Wheelhouse, R. AU - Brock, C. PY - 1997 DA - 1997// TI - Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials JO - Cancer Treat Rev VL - 23 UR - https://doi.org/10.1016/S0305-7372(97)90019-0 DO - 10.1016/S0305-7372(97)90019-0 ID - Newlands1997 ER - TY - JOUR AU - Lee, D. H. AU - Szczepanski, M. J. AU - Lee, Y. J. PY - 2009 DA - 2009// TI - Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells JO - J Cell Biochem VL - 106 UR - https://doi.org/10.1002/jcb.22098 DO - 10.1002/jcb.22098 ID - Lee2009 ER - TY - JOUR AU - Li, L. AU - Lin, J. AU - Sun, G. AU - Wei, L. AU - Shen, A. AU - Zhang, M. PY - 2016 DA - 2016// TI - Oleanolic acid inhibits colorectal cancer angiogenesis in vivo and in vitro via suppression of STAT3 and Hedgehog pathways JO - Mol Med Rep. VL - 13 UR - https://doi.org/10.3892/mmr.2016.5171 DO - 10.3892/mmr.2016.5171 ID - Li2016 ER - TY - JOUR AU - Lim, S. O. AU - Li, C. W. AU - Xia, W. AU - Cha, J. H. AU - Chan, L. C. AU - Wu, Y. PY - 2016 DA - 2016// TI - Deubiquitination and stabilization of PD-L1 by CSN5 JO - Cancer Cell VL - 30 UR - https://doi.org/10.1016/j.ccell.2016.10.010 DO - 10.1016/j.ccell.2016.10.010 ID - Lim2016 ER - TY - JOUR AU - Colak, S. AU - Dijke, P. PY - 2017 DA - 2017// TI - Targeting TGF-β signaling in cancer JO - Trends Cancer. VL - 3 UR - https://doi.org/10.1016/j.trecan.2016.11.008 DO - 10.1016/j.trecan.2016.11.008 ID - Colak2017 ER - TY - JOUR AU - Pei, Z. AU - Fu, W. AU - Wang, G. PY - 2017 DA - 2017// TI - A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling JO - Biochem Biophys Res Commun VL - 493 UR - https://doi.org/10.1016/j.bbrc.2017.08.170 DO - 10.1016/j.bbrc.2017.08.170 ID - Pei2017 ER - TY - JOUR AU - Moffat, J. G. AU - Rudolph, J. AU - Bailey, D. PY - 2014 DA - 2014// TI - Phenotypic screening in cancer drug discovery—past, present and future JO - Nat Rev Drug Discov. VL - 13 UR - https://doi.org/10.1038/nrd4366 DO - 10.1038/nrd4366 ID - Moffat2014 ER - TY - JOUR AU - Huang, M. AU - Lu, J. J. AU - Huang, M. Q. AU - Bao, J. L. AU - Chen, X. P. AU - Wang, Y. T. PY - 2012 DA - 2012// TI - Terpenoids: natural products for cancer therapy JO - Expert Opin Investig Drugs VL - 21 UR - https://doi.org/10.1517/13543784.2012.727395 DO - 10.1517/13543784.2012.727395 ID - Huang2012 ER - TY - JOUR AU - Lu, J. J. AU - Bao, J. L. AU - Wu, G. S. AU - Xu, W. S. AU - Huang, M. Q. AU - Chen, X. P. PY - 2013 DA - 2013// TI - Quinones derived from plant secondary metabolites as anti-cancer agents JO - Anticancer Agents Med Chem VL - 13 ID - Lu2013 ER - TY - JOUR AU - Lu, J. J. AU - Bao, J. L. AU - Chen, X. P. AU - Huang, M. AU - Wang, Y. T. PY - 2012 DA - 2012// TI - Alkaloids isolated from natural herbs as the anticancer agents JO - Evid Based Complement Altern Med. VL - 2012 ID - Lu2012 ER - TY - JOUR AU - Xu, X. H. AU - Li, T. AU - Fong, C. M. AU - Chen, X. AU - Chen, X. J. AU - Wang, Y. T. PY - 2016 DA - 2016// TI - Saponins from Chinese medicines as anticancer agents JO - Molecules VL - 21 UR - https://doi.org/10.3390/molecules21101326 DO - 10.3390/molecules21101326 ID - Xu2016 ER - TY - JOUR AU - Venkata Sairam, K. AU - Gurupadayya, B. M. AU - Chandan, R. S. AU - Nagesha, D. K. AU - Vishwanathan, B. PY - 2016 DA - 2016// TI - A review on chemical profile of coumarins and their therapeutic role in the treatment of cancer JO - Curr Drug Deliv VL - 13 UR - https://doi.org/10.2174/1567201812666150702102800 DO - 10.2174/1567201812666150702102800 ID - Venkata Sairam2016 ER - TY - JOUR AU - Yao, H. AU - Liu, J. AU - Xu, S. AU - Zhu, Z. AU - Xu, J. PY - 2017 DA - 2017// TI - The structural modification of natural products for novel drug discovery JO - Expert Opin Drug Discov VL - 12 UR - https://doi.org/10.1080/17460441.2016.1272757 DO - 10.1080/17460441.2016.1272757 ID - Yao2017 ER - TY - JOUR AU - Li, Q. Y. AU - Zu, Y. G. AU - Shi, R. Z. AU - Yao, L. P. PY - 2006 DA - 2006// TI - Review camptothecin: current perspectives JO - Curr Med Chem VL - 13 UR - https://doi.org/10.2174/092986706777585004 DO - 10.2174/092986706777585004 ID - Li2006 ER - TY - JOUR AU - Sriram, D. AU - Yogeeswari, P. AU - Thirumurugan, R. AU - Ratan, B. a. l. T. PY - 2005 DA - 2005// TI - Camptothecin and its analogues: a review on their chemotherapeutic potential JO - Nat Prod Res VL - 19 UR - https://doi.org/10.1080/14786410412331299005 DO - 10.1080/14786410412331299005 ID - Sriram2005 ER - TY - JOUR AU - Ding, C. AU - Tian, Q. AU - Li, J. AU - Jiao, M. AU - Song, S. AU - Wang, Y. PY - 2018 DA - 2018// TI - Structural modification of natural product tanshinone I leading to discovery of novel nitrogen-enriched derivatives with enhanced anticancer profile and improved drug-like properties JO - J Med Chem VL - 61 UR - https://doi.org/10.1021/acs.jmedchem.7b01259 DO - 10.1021/acs.jmedchem.7b01259 ID - Ding2018 ER - TY - JOUR AU - Lu, P. AU - Zhang, F. C. AU - Qian, S. W. AU - Li, X. AU - Cui, Z. M. AU - Dang, Y. J. PY - 2016 DA - 2016// TI - Artemisinin derivatives prevent obesity by inducing browning of WAT and enhancing BAT function JO - Cell Res VL - 26 UR - https://doi.org/10.1038/cr.2016.108 DO - 10.1038/cr.2016.108 ID - Lu2016 ER - TY - JOUR AU - Efferth, T. PY - 2018 DA - 2018// TI - Beyond malaria: the inhibition of viruses by artemisinin-type compounds JO - Biotechnol Adv UR - https://doi.org/10.1016/j.biotechadv.2018.01.001 DO - 10.1016/j.biotechadv.2018.01.001 ID - Efferth2018 ER - TY - JOUR AU - Ma, N. AU - Wang, Y. AU - Zhao, B. X. AU - Ye, W. C. AU - Jiang, S. PY - 2015 DA - 2015// TI - The application of click chemistry in the synthesis of agents with anticancer activity JO - Drug Des Dev Ther. VL - 9 ID - Ma2015 ER - TY - JOUR AU - Wang, R. AU - Li, L. AU - Zhang, S. AU - Li, Y. AU - Wang, X. AU - Miao, Q. PY - 2018 DA - 2018// TI - A novel enediyne-integrated antibody-drug conjugate shows promising antitumor efficacy against CD30(+) lymphomas JO - Mol Oncol. VL - 12 UR - https://doi.org/10.1002/1878-0261.12166 DO - 10.1002/1878-0261.12166 ID - Wang2018 ER - TY - JOUR AU - Xu, W. AU - Xing, F. J. AU - Dong, K. AU - You, C. AU - Yan, Y. AU - Zhang, L. PY - 2015 DA - 2015// TI - Application of traditional Chinese medicine preparation in targeting drug delivery system JO - Drug Deliv. VL - 22 UR - https://doi.org/10.3109/10717544.2014.892545 DO - 10.3109/10717544.2014.892545 ID - Xu2015 ER - TY - JOUR AU - Li, W. AU - Yin, H. AU - Bardelang, D. AU - Xiao, J. AU - Zheng, Y. AU - Wang, R. PY - 2017 DA - 2017// TI - Supramolecular formulation of nitidine chloride can alleviate its hepatotoxicity and improve its anticancer activity JO - Food Chem Toxicol VL - 109 UR - https://doi.org/10.1016/j.fct.2017.02.022 DO - 10.1016/j.fct.2017.02.022 ID - Li2017 ER - TY - JOUR AU - Qi, F. AU - Zhao, L. AU - Zhou, A. AU - Zhang, B. AU - Li, A. AU - Wang, Z. PY - 2015 DA - 2015// TI - The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer JO - Biosci Trends. VL - 9 UR - https://doi.org/10.5582/bst.2015.01019 DO - 10.5582/bst.2015.01019 ID - Qi2015 ER - TY - JOUR AU - Qi, F. AU - Li, A. AU - Inagaki, Y. AU - Gao, J. AU - Li, J. AU - Kokudo, N. PY - 2010 DA - 2010// TI - Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer JO - Biosci Trends. VL - 4 ID - Qi2010 ER - TY - JOUR AU - Cheng, Y. C. AU - Tsai, M. Y. AU - Chen, C. J. AU - Hung, Y. C. PY - 2015 DA - 2015// TI - Combination therapy of traditional Chinese medicine and Western medicine to treat refractory polymyositis: a case report JO - J Altern Complement Med VL - 21 UR - https://doi.org/10.1089/acm.2014.0145 DO - 10.1089/acm.2014.0145 ID - Cheng2015 ER - TY - JOUR AU - Chen, S. AU - Flower, A. AU - Ritchie, A. AU - Liu, J. AU - Molassiotis, A. AU - Yu, H. PY - 2010 DA - 2010// TI - Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: a systematic review JO - Lung Cancer. VL - 68 UR - https://doi.org/10.1016/j.lungcan.2009.11.008 DO - 10.1016/j.lungcan.2009.11.008 ID - Chen2010 ER - TY - JOUR AU - Gao, Y. AU - Chu, S. AU - Shao, Q. AU - Zhang, M. AU - Xia, C. AU - Wang, Y. PY - 2017 DA - 2017// TI - Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice JO - Free Radic Res. VL - 51 UR - https://doi.org/10.1080/10715762.2016.1234710 DO - 10.1080/10715762.2016.1234710 ID - Gao2017 ER - TY - JOUR AU - Yu, J. AU - Wang, C. AU - Kong, Q. AU - Wu, X. AU - Lu, J. J. AU - Chen, X. PY - 2018 DA - 2018// TI - Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products JO - Phytomedicine VL - 40 UR - https://doi.org/10.1016/j.phymed.2018.01.009 DO - 10.1016/j.phymed.2018.01.009 ID - Yu2018 ER - TY - JOUR AU - Sahu, B. D. AU - Kumar, J. M. AU - Kuncha, M. AU - Borkar, R. M. AU - Srinivas, R. AU - Sistla, R. PY - 2016 DA - 2016// TI - Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice JO - Life Sci VL - 144 UR - https://doi.org/10.1016/j.lfs.2015.11.018 DO - 10.1016/j.lfs.2015.11.018 ID - Sahu2016 ER - TY - JOUR AU - Jia, Y. AU - Zuo, D. AU - Li, Z. AU - Liu, H. AU - Dai, Z. AU - Cai, J. PY - 2014 DA - 2014// TI - Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway JO - Chem Pharm Bull VL - 62 UR - https://doi.org/10.1248/cpb.c13-00556 DO - 10.1248/cpb.c13-00556 ID - Jia2014 ER - TY - JOUR AU - Pirker, R. AU - Pereira, J. R. AU - Szczesna, A. AU - Pawel, J. AU - Krzakowski, M. AU - Ramlau, R. PY - 2009 DA - 2009// TI - Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial JO - Lancet. VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60569-9 DO - 10.1016/S0140-6736(09)60569-9 ID - Pirker2009 ER - TY - JOUR AU - Li, T. AU - Chen, X. AU - Chen, X. AU - Ma, D. L. AU - Leung, C. H. AU - Lu, J. J. PY - 2016 DA - 2016// TI - Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells JO - Sci Rep. VL - 6 UR - https://doi.org/10.1038/srep37997 DO - 10.1038/srep37997 ID - Li2016 ER - TY - JOUR AU - Li, T. AU - Chen, X. AU - Dai, X. Y. AU - Wei, B. AU - Weng, Q. J. AU - Chen, X. PY - 2017 DA - 2017// TI - Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor JO - Toxicol Appl Pharmacol VL - 330 UR - https://doi.org/10.1016/j.taap.2017.07.006 DO - 10.1016/j.taap.2017.07.006 ID - Li2017 ER - TY - JOUR AU - Zhu, H. AU - Ding, W. J. AU - Wu, R. AU - Weng, Q. J. AU - Lou, J. S. AU - Jin, R. J. PY - 2010 DA - 2010// TI - Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol JO - Cancer Invest VL - 28 UR - https://doi.org/10.3109/07357900903095664 DO - 10.3109/07357900903095664 ID - Zhu2010 ER - TY - JOUR AU - Bhaw-Luximon, A. AU - Jhurry, D. PY - 2017 DA - 2017// TI - Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives JO - Cancer Chemother Pharmacol VL - 79 UR - https://doi.org/10.1007/s00280-017-3251-7 DO - 10.1007/s00280-017-3251-7 ID - Bhaw-Luximon2017 ER - TY - JOUR AU - Guan, Z. AU - Lan, H. AU - Chen, X. AU - Jiang, X. AU - Li, Z. AU - Yu, X. PY - 2017 DA - 2017// TI - Synergistic effects and mechanism of Danshen injection in combination with chemotherapy and antiangiogenic therapy for colon cancer JO - Int J Clin Exp Med. VL - 10 ID - Guan2017 ER - TY - JOUR AU - Holohan, C. AU - Schaeybroeck, S. AU - Longley, D. B. AU - Johnston, P. G. PY - 2013 DA - 2013// TI - Cancer drug resistance: an evolving paradigm JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3599 DO - 10.1038/nrc3599 ID - Holohan2013 ER - TY - JOUR AU - Gottesman, M. M. PY - 2002 DA - 2002// TI - Mechanisms of cancer drug resistance JO - Annu Rev Med VL - 53 UR - https://doi.org/10.1146/annurev.med.53.082901.103929 DO - 10.1146/annurev.med.53.082901.103929 ID - Gottesman2002 ER - TY - JOUR AU - Singh, A. AU - Settleman, J. PY - 2010 DA - 2010// TI - EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.215 DO - 10.1038/onc.2010.215 ID - Singh2010 ER - TY - JOUR AU - Li, Y. AU - Wang, Y. AU - Niu, K. AU - Chen, X. AU - Xia, L. AU - Lu, D. PY - 2016 DA - 2016// TI - Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation JO - Oncotarget. VL - 7 ID - Li2016 ER - TY - JOUR AU - Chen, Q. AU - Qin, R. AU - Fang, Y. AU - Li, H. PY - 2015 DA - 2015// TI - Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway JO - Cell Physiol Biochem VL - 36 UR - https://doi.org/10.1159/000430270 DO - 10.1159/000430270 ID - Chen2015 ER - TY - JOUR AU - Qi, Y. B. AU - Wu, J. H. AU - Liu, B. Y. AU - Zhang, D. S. PY - 2005 DA - 2005// TI - Effects of Xue Fu Zhu Yu decoction on immune function of tumor-bearing mice JO - Modern Prev Med. VL - 5 ID - Qi2005 ER - TY - JOUR AU - Lu, X. F. PY - 2008 DA - 2008// TI - Experimental study on the effects of chemotherapy combined with Xuefu Zhuyu decoction polysaccharide on transplanted tumor in rats JO - Mod J Integr Tradit Chin West Med. VL - 16 ID - Lu2008 ER - TY - JOUR AU - Zhang, K. AU - Zhang, J. AU - Wang, X. AU - Wang, L. AU - Pugliese, M. AU - Passantino, A. PY - 2018 DA - 2018// TI - Cardioprotection of Sheng Mai Yin a classic formula on adriamycin induced myocardial injury in Wistar rats JO - Phytomedicine VL - 38 UR - https://doi.org/10.1016/j.phymed.2017.09.001 DO - 10.1016/j.phymed.2017.09.001 ID - Zhang2018 ER - TY - JOUR AU - Liu, S. H. AU - Cheng, Y. C. PY - 2012 DA - 2012// TI - Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy JO - J Ethnopharmacol VL - 140 UR - https://doi.org/10.1016/j.jep.2012.01.047 DO - 10.1016/j.jep.2012.01.047 ID - Liu2012 ER - TY - JOUR AU - Lam, W. AU - Bussom, S. AU - Guan, F. AU - Jiang, Z. AU - Zhang, W. AU - Gullen, E. A. PY - 2010 DA - 2010// TI - The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity JO - Sci Transl Med. VL - 2 UR - https://doi.org/10.1126/scitranslmed.3001270 DO - 10.1126/scitranslmed.3001270 ID - Lam2010 ER - TY - JOUR AU - Lam, W. AU - Jiang, Z. AU - Guan, F. AU - Huang, X. AU - Hu, R. AU - Wang, J. PY - 2015 DA - 2015// TI - PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment JO - Sci Rep. VL - 5 UR - https://doi.org/10.1038/srep09384 DO - 10.1038/srep09384 ID - Lam2015 ER - TY - JOUR AU - Gao, D. AU - Wang, B. AU - Huo, Z. AU - He, Y. AU - Polachi, N. AU - Lei, Z. PY - 2017 DA - 2017// TI - Analysis of chemical constituents in an herbal formula Jitong Ning Tablet JO - J Pharm Biomed Anal VL - 140 UR - https://doi.org/10.1016/j.jpba.2017.03.033 DO - 10.1016/j.jpba.2017.03.033 ID - Gao2017 ER - TY - JOUR AU - Li, X. AU - Sun, H. AU - Zhang, A. AU - Liu, Z. AU - Zou, D. AU - Song, Y. PY - 2017 DA - 2017// TI - High-throughput LC–MS method for the rapid characterization of multiple chemical constituents and metabolites of Da-Bu-Yin-Wan JO - J Sep Sci VL - 40 UR - https://doi.org/10.1002/jssc.201700568 DO - 10.1002/jssc.201700568 ID - Li2017 ER - TY - JOUR AU - Tilton, R. AU - Paiva, A. A. AU - Guan, J. Q. AU - Marathe, R. AU - Jiang, Z. AU - Eyndhoven, W. PY - 2010 DA - 2010// TI - A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906 JO - Chin Med. VL - 5 UR - https://doi.org/10.1186/1749-8546-5-30 DO - 10.1186/1749-8546-5-30 ID - Tilton2010 ER - TY - JOUR AU - Wang, L. AU - Zhou, G. B. AU - Liu, P. AU - Song, J. H. AU - Liang, Y. AU - Yan, X. J. PY - 2008 DA - 2008// TI - Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia JO - Proc Natl Acad Sci USA. VL - 105 UR - https://doi.org/10.1073/pnas.0712365105 DO - 10.1073/pnas.0712365105 ID - Wang2008 ER - TY - JOUR AU - Liang, X. AU - Li, H. AU - Li, S. PY - 2014 DA - 2014// TI - A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study JO - Mol BioSyst VL - 10 UR - https://doi.org/10.1039/C3MB70507B DO - 10.1039/C3MB70507B ID - Liang2014 ER - TY - JOUR AU - Chen, M. AU - Yang, F. AU - Yang, X. AU - Lai, X. AU - Gao, Y. PY - 2016 DA - 2016// TI - Systematic understanding of mechanisms of a Chinese herbal formula in treatment of metabolic syndrome by an integrated pharmacology approach JO - Int J Mol Sci VL - 17 UR - https://doi.org/10.3390/ijms17122114 DO - 10.3390/ijms17122114 ID - Chen2016 ER - TY - JOUR AU - Li, S. P. AU - Zhao, J. AU - Yang, B. PY - 2011 DA - 2011// TI - Strategies for quality control of Chinese medicines JO - J Pharm Biomed Anal VL - 55 UR - https://doi.org/10.1016/j.jpba.2010.12.011 DO - 10.1016/j.jpba.2010.12.011 ID - Li2011 ER - TY - JOUR AU - Liang, Y. AU - Xie, P. AU - Chau, F. PY - 2010 DA - 2010// TI - Chromatographic fingerprinting and related chemometric techniques for quality control of traditional Chinese medicines JO - J Sep Sci VL - 33 UR - https://doi.org/10.1002/jssc.200900653 DO - 10.1002/jssc.200900653 ID - Liang2010 ER - TY - JOUR AU - Hall, A. B. AU - Tolonen, A. C. AU - Xavier, R. J. PY - 2017 DA - 2017// TI - Human genetic variation and the gut microbiome in disease JO - Nat Rev Genet VL - 18 UR - https://doi.org/10.1038/nrg.2017.63 DO - 10.1038/nrg.2017.63 ID - Hall2017 ER - TY - JOUR AU - Li, J. AU - Sung, C. Y. AU - Lee, N. AU - Ni, Y. AU - Pihlajamaki, J. AU - Panagiotou, G. PY - 2016 DA - 2016// TI - Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice JO - Proc Natl Acad Sci USA. VL - 113 UR - https://doi.org/10.1073/pnas.1518189113 DO - 10.1073/pnas.1518189113 ID - Li2016 ER - TY - JOUR AU - Peuker, K. AU - Muff, S. AU - Wang, J. AU - Kunzel, S. AU - Bosse, E. AU - Zeissig, Y. PY - 2016 DA - 2016// TI - Epithelial calcineurin controls microbiota-dependent intestinal tumor development JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4072 DO - 10.1038/nm.4072 ID - Peuker2016 ER - TY - JOUR AU - Vetizou, M. AU - Pitt, J. M. AU - Daillere, R. AU - Lepage, P. AU - Waldschmitt, N. AU - Flament, C. PY - 2015 DA - 2015// TI - Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota JO - Science VL - 350 UR - https://doi.org/10.1126/science.aad1329 DO - 10.1126/science.aad1329 ID - Vetizou2015 ER - TY - JOUR AU - Sivan, A. AU - Corrales, L. AU - Hubert, N. AU - Williams, J. B. AU - Aquino-Michaels, K. AU - Earley, Z. M. PY - 2015 DA - 2015// TI - Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy JO - Science VL - 350 UR - https://doi.org/10.1126/science.aac4255 DO - 10.1126/science.aac4255 ID - Sivan2015 ER - TY - JOUR AU - Schneider, G. PY - 2018 DA - 2018// TI - Automating drug discovery JO - Nat Rev Drug Discov. VL - 17 UR - https://doi.org/10.1038/nrd.2017.232 DO - 10.1038/nrd.2017.232 ID - Schneider2018 ER -